Implantable Brain-Computer Interface Collaborative Community (iBCI-CC) to Drive Innovation in Neurotechnology

Mass General Brigham is establishing the Implantable Brain-Computer Interface Collaborative Community (iBCI-CC). This is the first Collaborative Community in the clinical neurosciences that has participation from the U.S. Food and Drug Administration (FDA). The Christopher & Dana Reeve Foundation is proud to join this novel collaborative community and is represented by Cristin Welle, PhD, associate professor of neurosurgery at the University of Colorado Anschutz Medical Campus in the School of Medicine and a member of the Reeve Foundation’s Scientific Advisory Board.


Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks